IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026)

IM Cannabis' (IMCC) quarterly Income from Continuing Operations came in at 1828847.88 in Q1 2026, down 1897.4% year-on-year from 101749.81 in Q1 2025, and up 67.58% quarter-over-quarter from 5640600.7 in Q4 2025.

IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026) Analysis & Trends

IM Cannabis' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 1828847.88 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 1897.4% year-over-year to 1828847.88 in Q1 2026; TTM through Mar 2026 was 10415739.95, a 203.59% decrease from a year earlier, with the FY2025 full-year figure at 8425763.83, down 6.27% from the prior year.
  • Income from Continuing Operations rose to 1828847.88 in Q1 2026 per IMCC's latest filing, from 5640600.7 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 3162061.52 in Q3 2022 and bottomed at 31126435.92 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 2526821.73 (2024), against an average of 4073777.27.
  • Across the five-year window, Income from Continuing Operations jumped 379.57% in 2022 and sank 2553.06% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 31126435.92 in 2022, then surged by 60.03% to 12440093.69 in 2023, then jumped by 98.29% to 212607.19 in 2024, then sank by 2553.06% to 5640600.7 in 2025, then surged by 67.58% to 1828847.88 in 2026.
  • Per Business Quant, the three latest IMCC Income from Continuing Operations figures stand at 1828847.88 (Q1 2026), 5640600.7 (Q4 2025), and 2808444.29 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn -1.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.83 Mn
Dec 31, 2025 -5.64 Mn
Sep 30, 2025 -2.81 Mn
Jun 30, 2025 -137,847.09
Mar 31, 2025 101,749.81
Dec 31, 2024 -212,607.19
Sep 30, 2024 -793,163.79
Jun 30, 2024 -2.53 Mn
Mar 31, 2024 -4.55 Mn
Dec 31, 2023 -12.44 Mn
Sep 30, 2023 1.59 Mn
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -652,412.19
Dec 31, 2022 -31.13 Mn
Sep 30, 2022 3.16 Mn
Jun 30, 2022 -2.77 Mn
Mar 31, 2022 -5.75 Mn
Dec 31, 2021 -6.63 Mn
Sep 30, 2021 659,359.73
Jun 30, 2021 -4.14 Mn